Successful Primary Medical Therapy With Somatostatin Receptor Ligand in Acromegaly With Thyroid Cancer

Journal of the ASEAN Federation of Endocrine Societies - Philippines
doi 10.15605/jafes.03.02.12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Journal of the ASEAN Federation of Endocrine Societies (JAFES)

Related search

Medical Treatment With Somatostatin Analogues in Acromegaly: Position Statement

The Korean Journal of Medicine
2019English

Somatostatin-Receptor Scintigraphy in Primary Breast Cancer

The Lancet
Medicine
1994English

Somatostatin Receptor-Targeted Radiopeptide Therapy in Patients With Progressive Unresectable Meningioma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Postoperative Use of Somatostatin Analogs and Mortality in Patients With Acromegaly.

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2019English

Growth Hormone Values After an Oral Glucose Load Do Not Add Clinically Useful Information in Patients With Acromegaly on Long-Term Somatostatin Receptor Ligand Treatment

Endocrine
2013English

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients With Acromegaly

PLoS ONE
Multidisciplinary
2014English

Interpreting Biochemical Control Response Rates With First-Generation Somatostatin Analogues in Acromegaly

Pituitary
EndocrinologyMetabolismDiabetes
2015English

Pegvisomant in Combination With Long-Acting Somatostatin Analogues in Acromegaly: The Role of the GH Receptor Deletion of Exon 3

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2015English

State of the Art Paper Thyroid Diseases in Patients With Acromegaly

Archives of Medical Science
Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy